Steris PLC
STE: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$955.00 | Yzlwzly | Gdfylvwcx |
Steris Earnings: Healthy Growth Across All Sectors Brings Strong Start to Fiscal Year
Narrow-moat Steris’ first-quarter results were in line with our expectations. Quarterly revenue was $1.3 billion, translating to 6% year-over-year growth in constant currency. The company reiterated its fiscal 2025 revenue guidance of $5.47 billion-$5.52 billion, or 6%-7% growth on a constant-currency basis. We are maintaining our $231 fair value estimate and view Steris’ current market price as about fairly valued.